A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
about
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patientsInteraction of TAFII105 with selected p65/RelA dimers is associated with activation of subset of NF-kappa B genesEmerging roles for the non-canonical IKKs in cancerDepletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoformsGATA-1 and Gfi-1B interplay to regulate Bcl-xL transcriptionThe NF-κB Pathway and Cancer Stem CellsNuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activityHydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signalingRole of ABL family kinases in cancer: from leukaemia to solid tumoursInactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-AblProgressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesisGene set analysis exploiting the topology of a pathway.The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance.Signaling pathways activated by oncogenic forms of Abl tyrosine kinase.Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells.The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration.Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion.Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl.NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation.Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemiaControl of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.Jak2 is involved in c-Myc induction by Bcr-Abl.NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.Studying the pathogenesis of BCR-ABL+ leukemia in mice.NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity.Endoplasmic reticulum stress activates telomerase.NF-κB addiction and its role in cancer: 'one size does not fit all'.NF-kappaB and cancer: how intimate is this relationshipOncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathwayBCR/ABL inhibition by an escort/phosphatase fusion proteinPilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.Considerations for targeting malignant stem cells in leukemia.Novel therapies for patients with chronic myeloid leukemia.MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825ROCK I-mediated activation of NF-kappaB by RhoB
P2860
Q22254246-4978FB48-2A0F-4A92-99F9-D006CF1F70BDQ22254261-150CF190-6261-4C16-94E5-3A14E800AF06Q24305225-E6E2A353-50B1-46A5-9BA2-E85850D7B3B9Q24658292-4F1F8C30-A65C-4F2B-B47B-6A385565F9BDQ24683168-70AB2AC6-9676-4142-8B47-D04980C03902Q26750605-521F4F2E-CC87-4726-BC78-2AB6C5AD27B9Q28383134-6B39E3EA-6B56-4D37-8A2F-F85FFB5D83FAQ28387183-79B99673-8D80-486C-B13A-4B9D9B036432Q28396643-B60D220A-2CBF-4512-87C7-5EB02758E38BQ28588928-ECFC237E-658B-4C86-B2B7-BCDCC339614EQ30168802-3213BAEB-62FF-4F81-A459-93D2F0576151Q30175784-000AC13B-33BB-4DBC-A148-FF7346649385Q30988680-CF80ACA4-6BA8-4813-B774-C5EE2766AFC9Q33226589-87C9E6F4-AD7A-4200-8A93-20C6F77F7386Q33663180-DB463966-6A77-46D7-A1AA-1752048584D9Q33747277-A88DFCDE-B34D-42EF-A3C9-6574ABD9FC14Q33768553-02022F92-8991-41CC-AB35-365481BEEF12Q33872322-2FF80455-B637-4D81-A564-607E5119C62DQ33908547-0AA49F43-A249-407D-ABD5-0FF86BBB2297Q33944952-B721B061-5B61-4040-A90F-B6B2A73FA5F7Q33959017-3475E605-BED8-427D-908A-C20E45EB0E66Q33960372-CA772361-E1A6-47C9-A31B-14AD674F19ADQ34032219-3BDE04C6-F75C-4D6B-8BC9-0AAA9223E32EQ34131747-1E231AF4-DE9A-494A-928B-5F7B646E8E23Q34153616-7A54DC84-0962-41B7-BF05-C6E8CC823B98Q34283905-A4B642FF-AFF3-424D-AFBB-F75B87798C89Q34819481-9C9859C3-4325-47BB-ACA9-2B0D9763354CQ35022543-FA180D91-8C4E-4D43-B70F-218FB245130DQ35071293-21AD4764-5816-42DF-952A-CBC9FB28A627Q35080451-9544344F-268D-439A-B285-99C13AAC2EAEQ35120893-1E453BCE-5A3B-40AA-9494-59D77B98EB48Q35143597-9872751F-1542-4A44-9BCF-8219350C3B71Q35200289-FABD1ECC-EAC1-4C95-8728-F0358BDCEA20Q35410948-885BF4B8-C6D7-40DA-AE19-1D4CBEE112E6Q35510549-5A8C5B4A-F6A6-4303-93C9-69B82BC1570EQ35635449-5803C580-1C52-45F8-BFB8-5D31F30A40A8Q35692619-95923934-018E-43E3-ACD7-CE1AD1785DBBQ35728742-E939269E-D54F-4BAC-A076-9D1479DC3F9FQ35804449-7BF85396-3F3E-4FDC-A7AB-A5347188DF45Q36156141-3C48D794-4302-496D-914F-B70454487B98
P2860
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@ast
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@en
type
label
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@ast
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@en
prefLabel
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@ast
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@en
P2093
P2860
P356
P1433
P1476
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
@en
P2093
A M Pendergast
A S Baldwin
G W Reuther
J Y Reuther
P2860
P304
P356
10.1101/GAD.12.7.968
P577
1998-04-01T00:00:00Z